Nitric oxide inhibits renal cytochrome P450-dependent epoxygenases in the rat

Clinical and Experimental Pharmacology and Physiology

Volumn 29, Issue 11, 2002, Pages 990-995

  Oyekan, Adebayo ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Arachidonic acid; Cytochrome P450; Epoxyeicosa trienoic acids; Nitric oxide; Renal vasodilation

Indexed keywords

ARACHIDONIC ACID; CARBON 14; CYTOCHROME P450; DIHYDROXYICOSATRIENOIC ACID; DRINKING WATER; ENDOTOXIN; EPOXIDE; EPOXYGENASE; EPOXYICOSATRIENOIC ACID; ICOSATRIENOIC ACID; INDOMETACIN; LIPOPOLYSACCHARIDE; MICONAZOLE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; OXYGENASE; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKING AGENT; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; HYDRATION; KIDNEY; KIDNEY PERFUSION; MALE; MICROSOME; NONHUMAN; RAT; TIME; VASODILATATION;

ANIMALS; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; KIDNEY; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036400605     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2002.03762.x     Document Type: Article

References (30)

1. Karara A, Makita K, Jacobson HR et al. Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenase. J. Biol. Chem. 1993; 268: 13 565-70.
2. Imaoka S, Yamazoe Y, Kato R, Funae Y. Hormonal regulation of rat cytochrome P450s by androgen and pituitary. Arch. Biochem. Biophys. 1992; 299: 179-84.
3. McGiff JC. Cytochrome P-450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol. 1991; 31: 339-69.
4. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 1996; 78: 415-23.
5. Quilley J, Fulton D, McGiff JC. Hyperpolarizing factors. Biochem. Pharmacol. 1997; 54: 1059-70.
6. Fulton D, McGiff JC, Quilley J. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart. J. Pharmacol. Exp. Ther. 1998; 287: 497-503.
7. Fulton D, McGiff JC, Quilley J. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br. J. Pharmacol. 1991; 107: 722-5.
8. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. 1994; 481: 407-14.
9. Mombouli J-V, Vanhoutte PM. Endothelium-derived hyperpolarizing factor(s): Updating the unknown. Trends Pharmacol. Sci. 1997; 18: 252-6.
10. Khatsenko OG, Gross SS, Rifkind AB, Vane JR. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl Acad. Sci. USA 1993; 90: 11 147-51.
11. Alonso-Galicia M, Drummond HA, Reddy KK, Falck JR, Roman RR. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 1997; 29: 320-5.
12. Oyekan AO, Youseff T, Fulton D, Quilley J, McGiff JC. Renal cytochrome P450 ω-hydroxylase and epoxygenase activity is differentially modified by nitric oxide and NaCl. J. Clin. Invest. 1999; 104: 1131-7.
13. White KA, Marletta MA. Nitric oxide synthase is a cytP450 type hemoprotein. Biochemistry 1992; 31: 6627-31.
14. Capdevilla JH, Wei S, Yan J et al. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J. Biol. Chem. 1992; 267: 21 720-6.
15. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714-18.
16. Dudek RR, Conforto A, Pinto V, Wildhirt S, Suzuki H. Inhibition of endothelial nitric oxide synthase by cytochrome P450 reductase inhibitors. Proc. Soc. Exp. Biol. Med. 1995; 209: 60-4.
17. Yuan R, Sumi M, Benet LZ. Investigation of aortic CYP3A bioactivation of nitroglycerin in vivo. J. Pharmacol. Exp. Ther. 1997; 281: 1499-505.
18. Carlson TJ, Billings RE. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P450. Mol. Pharmacol. 1996; 49: 796-801.
19. Oyekan AO, McGiff JC. Functional response of the rat kidney to inhibition of nitric oxide synthesis: Role of cytochrome P450-derived arachidonate metabolites. Br. J. Pharmacol. 1998; 125: 1065-73.
20. Oyekan AO, McGiff JC, Quilley J. Cytochrome P-450-dependent vasodilation of rat kidney by arachidonic acid. Am. J. Physiol. 1991; 261: H714-19.
21. Oyekan AO, Balazy M, McGiff JC. Renal oxygenases. Differential contribution to vasoconstriction induced by endothelin-1 and angiotensin II. Am. J. Physiol. 1997; 273: R293-300.
22. Fulton D, Falck JR, McGiff JC, Carroll MA, Quilley J. A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol. J. Lipid Res. 1998; 39: 1713-21.
23. Schwartzman ML, Abraham NG, Carroll MA, Levere RD, McGiff JC. Regulation of arachidonic acid metabolism by cytochrome P450 in the rabbit kidney. Biochem. J. 1986; 238: 283-90.
24. Sewer MB, Koop DR, Morgan ET. Endotoxemia in rats is associated with induction of the P450A subfamily and suppression of several other forms of cytochrome P450. Drug Metab. Dispos. 1996; 24: 401-7.
25. Fisslthaler B, Hinsch N, Chataigneau T et al. Nifedipine increases CYP2C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension, 2000; 36: 270-5.
26. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 1996; 94: 3341-7.
27. Nishikawa Y, Stepp DW, Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am. J. Physiol. 2000; 79: H459-65.
28. 2. Circ. Res. 1999; 84: 53-63.
29. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994; 368: 850-3.
30. Buxton IL, Kaiser RA, Malmquist NA, Tichenor S. NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP. Br. J. Pharmacol. 2001; 134: 206-14.